Saunders DE - Search Results

1

Additive inhibition of RL95-2 endometrial carcinoma cell growth by carboplatin and 1,25 dihydroxyvitamin D3.

Saunders DE, Christensen C, Wappler NL, Cho YL, Lawrence WD, Malone JM, Malviya VK, Deppe G. Saunders DE, et al. Gynecol Oncol. 1993 Nov;51(2):155-9. doi: 10.1006/gyno.1993.1264. Gynecol Oncol. 1993. PMID: 8276288

2

The use of a human endometrial carcinoma cell line (RL-95) for in vitro testing of chemotherapeutic agents.

Christensen C, Deppe G, Saunders D, Malviya V. Christensen C, et al. Gynecol Oncol. 1987 Sep;28(1):25-33. doi: 10.1016/s0090-8258(87)80005-7. Gynecol Oncol. 1987. PMID: 3653767

3

Treatment of recurrent and metastatic endometrial carcinoma with cisplatin and doxorubicin.

Deppe G, Malviya VK, Malone JM, Christensen CW, Saunders D. Deppe G, et al. Eur J Gynaecol Oncol. 1994;15(4):263-6. Eur J Gynaecol Oncol. 1994. PMID: 7957332

4

Receptors for 1,25-dihydroxyvitamin D3 in gynecologic neoplasms.

Saunders DE, Christensen C, Lawrence WD, Malviya VK, Malone JM, Williams JR, Deppe G. Saunders DE, et al. Gynecol Oncol. 1992 Feb;44(2):131-6. doi: 10.1016/0090-8258(92)90028-h. Gynecol Oncol. 1992. PMID: 1312051

5

Combined effects of 1,25-dihydroxyvitamin D3 and platinum drugs on the growth of MCF-7 cells.

Cho YL, Christensen C, Saunders DE, Lawrence WD, Deppe G, Malviya VK, Malone JM. Cho YL, et al. Among authors: saunders de. Cancer Res. 1991 Jun 1;51(11):2848-53. Cancer Res. 1991. PMID: 2032225

6

Inhibition of breast and ovarian carcinoma cell growth by 1,25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone.

Saunders DE, Christensen C, Williams JR, Wappler NL, Lawrence WD, Malone JM, Malviya VK, Deppe G. Saunders DE, et al. Anticancer Drugs. 1995 Aug;6(4):562-9. doi: 10.1097/00001813-199508000-00009. Anticancer Drugs. 1995. PMID: 7579560

7

Inhibition of c-myc in breast and ovarian carcinoma cells by 1,25-dihydroxyvitamin D3, retinoic acid and dexamethasone.

Saunders DE, Christensen C, Wappler NL, Schultz JF, Lawrence WD, Malviya VK, Malone JM, Deppe G. Saunders DE, et al. Anticancer Drugs. 1993 Apr;4(2):201-8. doi: 10.1097/00001813-199304000-00012. Anticancer Drugs. 1993. PMID: 8490200

8

Studies on type II progesterone receptor in MCF-7 cells.

Saunders DE, Christensen C, Brooks SC. Saunders DE, et al. Steroids. 1988 Sep;52(3):249-63. doi: 10.1016/0039-128x(88)90007-4. Steroids. 1988. PMID: 3254626

9

Paclitaxel-induced apoptosis in MCF-7 breast-cancer cells.

Saunders DE, Lawrence WD, Christensen C, Wappler NL, Ruan H, Deppe G. Saunders DE, et al. Int J Cancer. 1997 Jan 17;70(2):214-20. doi: 10.1002/(sici)1097-0215(19970117)70:2<214::aid-ijc13>3.0.co;2-i. Int J Cancer. 1997. PMID: 9009163

10

Reversal of alcohol's effects on neurite extension and on neuronal GAP43/B50, N-myc, and c-myc protein levels by retinoic acid.

Saunders DE, Hannigan JH, Zajac CS, Wappler NL. Saunders DE, et al. Brain Res Dev Brain Res. 1995 May 26;86(1-2):16-23. doi: 10.1016/0165-3806(95)00008-2. Brain Res Dev Brain Res. 1995. PMID: 7656409

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters